NanHua Bio-medicine Co., Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 156.4 million compared to CNY 102.63 million a year ago. Revenue was CNY 156.4 million compared to CNY 102.63 million a year ago.

Net income was CNY 0.540721 million compared to net loss of CNY 8.4 million a year ago. Basic earnings per share from continuing operations was CNY 0.0017 compared to basic loss per share from continuing operations of CNY 0.027 a year ago. Diluted earnings per share from continuing operations was CNY 0.0017 compared to diluted loss per share from continuing operations of CNY 0.027 a year ago.